T3 Defense's subsidiary Rimon has completed delivery of the first mobile counter-UAS (unmanned aerial system) launcher platform for Elbit Systems' Active Defense Division. These containerized, mobile tactical platforms enable rapid deployment and sustained operations against drone threats without relying on fixed infrastructure. This advancement addresses urgent operational needs on Israel's northern front by providing field-ready, self-contained systems that enhance aerial defense capabilities. Rimon is continuing to deliver additional units to support dynamic frontline environments.
The Global Initiative on Loneliness and Connection (GILC) convened the 2026 Global Connection Forum on June 17 to address the growing public health crisis of loneliness and social isolation, which contribute to serious health risks and societal divis...
The metastatic prostate cancer market is shifting from traditional hormone therapies to precision, biomarker-driven treatments, including novel PARP inhibitors and PSMA-targeted radioligand therapies. The market, valued at $11.5 billion in 2025 in ma...
The lupus nephritis clinical trial landscape is rapidly expanding with more than 30 pharmaceutical companies developing over 35 drugs targeting this serious autoimmune kidney condition. Key players like Novartis, Simcere, and Regeneron are advancing ...
VINCI has initiated a share buyback program by signing an agreement with an investment services provider to repurchase its shares up to a limit of €200 million. The program runs from June 11 to July 31, 2026, with the purchase price capped by shareho...
VINCI has initiated a share buyback program by signing an agreement with an investment service provider to repurchase its shares up to a value of €200 million. This program runs from June 11 to July 31, 2026, with purchase prices capped by the genera...
